Conclusion: This systematic review identifies the state and mechanism of action of emerging pharmacotherapies undergoing or having completed phase 2 and phase 3 clinical trials. The information provided herein furthers the understanding of obesity management, implying direct clinical implications and stimulating research initiatives.
Does Retatrutide help with weight loss?
Yes, for most people. 92% of 228 people who reported on Retatrutide for weight loss say it improved. 5% noticed no change and 4% say it got worse. That is about the typical result for weight loss (91% across 22 options).
Across all 325 first-hand reports on Retatrutide (any goal): worked for 76%, worked with downsides for 21%, did not work for 3%. Most reported side effects: nausea, fatigue, stomach issues, insomnia.
High-risk compound. Not an approved supplement; serious risks and legal restrictions apply. Nothing here is a recommendation to use it.
Ranked #5 of 22 for weight loss.
People it helped with weight loss
“Drastically reduced appetite: At 5mg, I experienced near-total suppression of hunger and cravings. Steady, effortless fat loss: I didn't have to track macros obsessively or do extreme cardio.”
“I've already lost around 10-15 lbs... My energy is dramatically better and more consistent.”
“Ive currently lost 45 pounds so far on retatrutide in 7 months...credit goes to reta.”
“I just finished a 9-week Retatrutide run ... dropped 28 pounds while holding onto strength and energy.”
Problems people report with Retatrutide
“I’ve tried Reta and it melted fat away at 1mg - I really disliked the increased heart rate (and it was only 8bpm) and the nuking of my HRV.”
What the research says
Conclusion: GLP-1 RAs and co-agonists are efficacious for weight loss, with reported safety concerns predominantly gastrointestinal in nature, when used among adults with overweight or obesity and without diabetes.
Conclusion: Retatrutide (both doses) and tirzepatide exhibited superior efficacy compared to other GLP-1 receptor agonists and polyagonists in reducing body weight and waist circumference. Patients without T2DM, those with a high BMI, and individuals undergoing longer treatment cycles demonstrated significantly greater weight loss and reductions in waist circumference. Dual or triple receptor agonists (GLP-1 plus glucose-dependent insulinotropic polypeptide and/or Glucagon receptor) are more effective for weight loss than GLP-1 receptor agonists.
Side effects people mention
What else is Retatrutide used for?
Information only — not medical advice. How we count